Affirmed by published opinion. Judge SMITH wrote the opinion, in which Judge WIDENER and Judge LUTTIG joined.
OPINION
Novant Health, Incorporated (“Novant”) appeals an order of the district court denying its motion for protective order and granting in part Dr. Ashutosh Ron Virma-ni’s motion to compel records related to medical peer reviews. Novant argues that the documents Virmani seeks to discover are privileged. Because we decline to recognize a privilege for medical peer review materials, we affirm the order of the district court.
I.
Dr. Virmani is an obstetrician-gynecologist who was granted medical staff membership and clinical privileges at Presbyterian Hospital and Presbyterian Hospital Matthews (collectively, “Presbyterian”).
The first review (the “First Peer Review”), conducted by Presbyterian’s OB/ GYN Committee, lasted five months, from March through August of 1995. The Committee reviewed all cases in which Virmani had been the primary care physician since August of 1993 and found 24 of the 102 cases to be problematic. Based on the Committee’s report, Novant suspended Virmani’s privileges, pending a review by Presbyterian’s Medical Board. At Virma-ni’s request, the Hearing Committee of the Medical Board, which is composed of three physicians, conducted a full hearing on November 21, 1995. Following that hearing, the Medical Board voted to terminate Vir-mani’s medical staff privileges. Presbyterian’s Board of Trustee’s upheld that decision on January 19,1996.
On January 22, 1996, Virmani filed an action against Novant in North Carolina state court, alleging that the manner in which Presbyterian had suspended Virma-ni’s privileges breached its bylaws. The trial court ordered Novant to give Virmani a new peer review proceeding, to be conducted by a peer review body composed of physicians from outside Presbyterian. In August of 1997, the North Carolina Court of Appeals affirmed the trial court’s order to the extent it required a second peer review, but reversed as to the requirement that the second peer review body consist of an external committee. See Virmani v. Presbyterian Health Servs. Corp.,
Virmani filed the instant action in federal court on January 15, 1999, alleging that the termination of his privileges constituted discrimination against him on the basis of his race and national origin, in violation
During discovery, Virmani sought to obtain, inter alia, all peer review records related to all reviews of physicians for any reason, during the twenty years preceding his request. Novant moved for a protective order, arguing that the peer review materials were privileged under North Carolina law, see N.C. Gen.Stat. § 131E-95(b) (1999), and pursuant to Federal Rule of Evidence 501. Virmani filed a motion to compel production of the materials.
The district court
On August 15, 2000, the district court denied Novant’s motion for reconsideration. The court certified its June 27, 2000, order for interlocutory appeal, and we granted Novant’s petition for leave to appeal.
II.
Novant argues on appeal that the district court erred in refusing to recognize a privilege for documents related to medical peer review proceedings. Federal Rule of Evidence 501, which governs privileges in federal courts, provides that
Except as otherwise required by the Constitution of the United States or provided by Act of Congress or in rules prescribed by the Supreme Court pursuant to statutory authority, the privilege of a witness, person, government, State, or political subdivision thereof shall be governed by the principles of the common law as they may be interpreted by the courts of the United States in the light of reason and experience.
Fed.R.Evid. 501.
Evidentiary privileges “are not lightly created,” United States v. Nixon,
Novant argues that confidentiality is essential to the effectiveness of medical peer review committees. Some courts have found that if a privilege is not accorded to the documents considered and produced by these committees, physicians would be reluctant to serve on the committees or would be less candid in their evaluations if they did serve; as a result, the quality of health care would suffer. See, e.g., HCA Health Servs. of Va., Inc. v. Levin,
A.
Novant identifies the following reasons underlying the Supreme Court’s decision in Jaffee to recognize a privilege for statements made by a patient to her therapist during counseling sessions: the privilege serves a compelling public end; rejection of the privilege would result in only a modest evidentiary benefit; and all fifty states and the District of Columbia have recognized the privilege. Novant argues that each of these reasons applies with equal or greater force in favor of recognizing a privilege for medical peer review materials in this case, where a physician has alleged that he was the victim of discrimination in the peer review process. We disagree.
The Court in Jaffee determined that the psychotherapist privilege would serve the private interest of protecting confidential communications between psychotherapist and patient and the public interest of “facilitating the provision of appropriate treatment for individuals suffering the effects of a mental or emotional problem.” Jaffee,
Significantly, the issue of privilege arose in Jaffee in an entirely different context than that of this case, in which Virmani’s claim of discrimination arises from the peer review process itself. Therefore, No-vant’s reliance on Jaffee is misplaced. In Jaffee, a police officer who had fatally shot a person was being sued by the decedent’s estate for use of excessive force. The plaintiff sought notes from counseling sessions in which the police officer participated after the traumatic incident. See id. at 5,
Our decision here is more properly guided by University of Pennsylvania v. EEOC,
“[C]onfidential material pertaining to other candidates for tenure in a similar time frame may demonstrate that persons with lesser qualifications were granted tenure or that some pattern of discrimination appears.... [T]he peer review material itself must be investigated to determine whether the evaluations are based in discrimination and whether they are reflected in the tenure decision.”
Id. (quoting EEOC v. Franklin & Marshall Coll.,
We agree with Novant that the privilege it seeks would serve important interests. However, as is the case in the academic context, the evidentiary benefit that will be realized by refusing to grant a privilege for medical peer review materials in a discrimination case is potentially great. The evidence Virmani seeks is crucial to his attempt to establish that he has been the subject of disparate treatment on the basis of race and ethnicity. To prove his allegations of disparate treatment, Virmani must compare the proceedings in his case against those involving similarly situated physicians. The interest in facilitating the eradication of discrimination by providing perhaps the only evidence that can establish its occurrence outweighs the interest in promoting candor in the medical peer review process. See, e.g., University of Pa.,
Novant further asserts that, as in Jaffee, evidence of the type that discrimination plaintiffs such as Virmani seek will not come into being if there is no medical peer review privilege, because physicians will be reluctant to speak openly and, in particular, will refrain from making remarks that would constitute evidence of discrimination. The evidence that Virmani seeks, however, is not evidence in the form of a “smoking gun,” but rather, evidence of disparate treatment on the basis of impermissible factors. Such evidence will not come into being in the peer review process only if such disparate treatment ceases to occur. Thus, unlike the situation in Jajfee,
Novant calls to our attention the fact that all fifty states and the District of Columbia have recognized some form of medical peer review privilege. The Supreme Court stated in Jaffee that “the policy decisions of the States bear on the question whether federal courts should recognize a new privilege,” and “the existence of a consensus among the States indicates that ‘reason and experience’ support recognition of the privilege.” Jaffee,
There is no evidence that state legislatures considered the potential impact on discrimination cases of a privilege for medical peer review proceedings. Thus, the states’ policy decisions, reflecting different concerns than those implicated here, do not inform the judgment of this court in this case. Weighing further against recognizing a privilege here is that, in contrast to a medical malpractice or defamation action, if a plaintiff succeeds in a discrimination case, he advances important public interests in addition to his personal interests. Cf. id. (refusing to recognize a privilege for medical disciplinary proceedings in an antitrust case and observing that if the plaintiff was successful in proving his claim, he would “vindicate not only his own right to practice medicine ..., but also the strong public interest in open and fair competition which is embodied in the Sherman Act under which the case arises”).
B.
We should not recognize a privilege “where it appears that Congress has considered the relevant competing concerns but has not provided the privilege itself.” University of Pa.,
Although we cannot conclude that Congress actually considered and rejected a privilege for medical review materials when enacting the HCQIA, it is clear that Congress considered the relevant competing interests — providing incentive and protection to physicians who would serve on review committees versus allowing putative victims of discrimination to pursue their claims' — and decided to give greater weight to the latter.
Congress’s findings with respect to the HCQIA reflect its concern that medical malpractice and the need to improve the quality of medical care were national problems. See 42 U.S.C.A. § 11101(1). Congress determined that effective peer review would provide a remedy to these problems. See id. § 11101(3). However, “[t]he threat of private money damage liability under Federal laws, including treble damage liability under Federal antitrust law, unreasonably discourages physicians from participating in effective professional peer review.” Id. § 11101(4). Thus, Congress concluded that “[tjhere is an overriding national need to provide incentive and protection for physicians engaging in effective professional peer review.” Id. § 11101(5). To provide this incentive and protection, Congress provided immunity from liability in damages to participants in the activities of professional review bodies meeting specified standards. See id. § 11111(a). However, Congress created an express exception to the immunity pro
Novant contends that Congress favors a medical peer review privilege, as evidenced by the enactment of a privilege for the Department of Defense and the Department of Veterans Affairs. See 10 U.S.C.A. § 1102(a) (West 1998) (providing that “[m]edical quality assurance records created by or for the Department of Defense as part of a medical quality assurance program are confidential and privileged”); 38 U.S.C.A. § 5705(a) (West 1991) (providing that “[r]ecords and documents created by the Department [of Veterans Affairs] as part of a medical quality-assurance program ... are confidential and privileged”). However, these provisions also demonstrate that Congress will create a medical peer review privilege when it is so inclined.
C.
Finally, Novant argues that recognition of the privilege is supported by cases from the Fifth and Seventh Circuits. In fact, the Seventh Circuit expressly declined to recognize a medical peer review privilege in Memorial Hospital v. Shadur,
Novant argues that the holding in Sha-dur was subsequently undermined by the Seventh Circuit in Marrese v. American Academy of Orthopaedic Surgeons,
The Fifth Circuit case cited by Novant does not support its position either. At
In summary, only the Seventh Circuit has squarely addressed the issue of whether peer review documents should be privileged in federal courts, and that court has declined to recognize the privilege.
III.
We hold that the interest in obtaining probative evidence in an action for discrimination outweighs the interest that would be furthered by recognition of a privilege for medical peer review materials. Therefore, we decline to recognize such a privilege. Accordingly, the order of the district court is affirmed.
AFFIRMED.
Notes
. The hospitals are non-parties that are subsidiaries of Novant, formerly known as Presbyterian Health Services Corporation.
. The case was referred to Magistrate Judge McKnight, pursuant to 28 U.S.C.A. § 636(c)(2) (West 1993).
. The rule continues: "However, in civil actions and proceedings, with respect to an element of a claim or defense as to which State law supplies the rule of decision, the privilege of a witness, person, government, State, or political subdivision thereof shall be determined in accordance with State law.” Fed.R.Evid. 501. If North Carolina law supplied the rule of decision, the materials would be privileged. See N.C. Gen.Stat. § 131E-95(b) (providing that "[t]he proceedings of a medical review committee, the records and materials it produces and the materials it considers ... shall not be subject to discovery or introduction into evidence in any civil ac-lion against a hospital”). This case involves a federal question together with pendent state law claims, however, and the Supreme Court has not addressed the question of whether federal common law controls in such a situation. See Jaffee v. Redmond,
. We emphasize that Novant seeks to prevent Virmani from discovering peer review documents for use in this case of alleged discrimination; patient confidentiality is not at issue here, nor is public disclosure of other confidential medical records. There is an important distinction between privilege and protection of documents, the former operating to shield the documents from production in the first instance, with the latter operating to preserve confidentiality when produced. An appropriate protective order can alleviate problems and concerns regarding both confidentiality and scope of the discovery material produced in a particular case. Indeed, in the district court's order of June 27, 2000, refusing to recognize a privilege for peer review materials, the court limited the scope of the discovery requests in terms of the time period covered and the medical specialty involved. Further, on September 12, 2000, a consent protective order was entered by the court, which order provided for the protection of confidential documents, and, in particular, restricted the use of the confidential documents to the instant action. A court likewise can protect the identities of third parties, i.e., the patients and the other physicians who were the subjects of prior peer reviews, as well as exclude or redact extraneous confidential medical information, through an appropriate order. See Marrese v. American Acad. of Orthopaedic Surgeons,
. Relevant case law from the Fifth and Seventh Circuits is discussed infra Part II.C.
. Crucial lo the Court's holding was its determination that Congress had balanced the relevant interests and had declined to create a privilege. See University of Pa.,
. Furthermore, the motivations of those seeking the privilege here differ from those in Jaffee. A patient in need of a psychotherapist would have a personal motivation to seek mental health treatment, which might be diminished in the absence of a privilege. A doctor called upon to serve on a medical peer review committee may have a sense of obligation to the public at large, in addition to a personal desire to maintain quality health care, which may overcome any reluctance to serve and be forthcoming on a peer review committee, even in the absence of a privilege. See LeMasters v. Christ Hosp.,
. One commentator has characterized the need for confidentiality of medical peer review materials as follows:
A physician’s qualifications, competence, and ethics all are called into question when a medical staff committee is requested to review his application for staff privileges, to determine the extent of his clinical privileges, or to assess the quality of his work. The nature of these activities suggests that committee participants may lose professional friends, as well as referrals, from physicians who receive unfavorable reviews. In addition, the committee members, and the hospital as well, may be exposed to costly litigation alleging defamation, the most common claim arising from committee activities.
Charles David Creech, Comment, The Medical Review Committee Privilege: A Jurisdictional Sutvey, 67 N.C. L.Rev. 179, 179 n. 4 (1988) (internal quotation marks omitted).
. The court, followed the reasoning of other district courts that had considered the issue and determined that Congress decided not to establish a privilege for peer review documents. Sea, e.g., Johnson v. Nyack Hosp.,
. Novant argues that, despite the fact that Congress failed to enact a privilege, Congress intended to protect medical peer review materials. Novant observes that Representative Waxman, the main sponsor of the House bill, stated that the bill was not intended to override state shield laws "that restrict the type of evidence that may be introduced in lawsuits challenging a disciplinary action in the context of peer review.” 132 Cong. Rec. 33,117 (1986). However, Representative Waxman also indicated that the bill was not intended to shield acts of discrimination. See id. at 30,766 ("Actions that violate civil rights laws . .. will not be protected under this bill.”).
. While the Seventh Circuit did, as Novant claims, consider the underlying policy of protecting the files at issue in its review of the district court’s discovery order and subsequent contempt order, the Seventh Circuit did not find that the interest in the confidentiality of the files was paramount. Rather, the court concluded that "there were various devices that the district judge could have used to reconcile the parties' competing needs.”
. Although the Fifth Circuit addressed the hospital’s argument that the documents sought were privileged, this portion of the opinion is dicta. See
. The district courts that have addressed the issue in discrimination cases have all rejected a medical peer review privilege. See, e.g., Holland, 911 F.Supp. at 389; Johnson v. Nyack Hosp.,
